Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 8.78% is 58% above its 5-year average of 5.55%, near the high end of its 5-year range (2.22%–8.78%).
As of the fiscal period ended Wednesday, December 31, 2025. 17.77% above its 12-month average of 7.46%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
8.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
7.46%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
6.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
5.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
5.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
5.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
5.07%
CURRENT VS TTM AVG
+17.77%
CURRENT VS 3Y AVG
+43.41%
CURRENT VS 5Y AVG
+58.25%
CURRENT VS 10Y AVG
+59.08%
CURRENT VS 15Y AVG
+68.66%
CURRENT VS 20Y AVG
+73.35%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+2.93%
vs the sector median at left
Boston Scientific Corporation
Market Cap
$69.46B
Return on Invested Capital (ROIC)
8.78%
TTM Avg
7.46%
3Y Avg
6.12%
5Y Avg
5.55%
Market Cap
$73.82B
Return on Invested Capital (ROIC)
7.35%
TTM Avg
7.02%
3Y Avg
7.07%
5Y Avg
6.50%
Market Cap
$60.57B
Return on Invested Capital (ROIC)
13.23%
TTM Avg
15.09%
3Y Avg
14.58%
5Y Avg
13.58%
Market Cap
$78.57B
Return on Invested Capital (ROIC)
8.51%
TTM Avg
9.70%
3Y Avg
12.91%
5Y Avg
18.22%
Market Cap
$60.00B
Return on Invested Capital (ROIC)
4.73%
TTM Avg
4.38%
3Y Avg
4.32%
5Y Avg
3.88%
Market Cap
$81.51B
Return on Invested Capital (ROIC)
6.65%
TTM Avg
6.70%
3Y Avg
7.11%
5Y Avg
7.33%
Market Cap
$53.87B
Return on Invested Capital (ROIC)
11.37%
TTM Avg
10.09%
3Y Avg
4.86%
5Y Avg
-0.22%
Market Cap
$87.16B
Return on Invested Capital (ROIC)
18.53%
TTM Avg
17.61%
3Y Avg
17.07%
5Y Avg
16.89%
Market Cap
$49.56B
Return on Invested Capital (ROIC)
11.40%
TTM Avg
11.07%
3Y Avg
14.43%
5Y Avg
15.83%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | $69.46B | 8.78% | 7.46% | 6.12% | 5.55% |
| Cigna Corporation (CI)vs › | $73.82B | 7.35% | 7.02% | 7.07% | 6.50% |
| Cencora, Inc. (COR)vs › | $60.57B | 13.23% | 15.09% | 14.58% | 13.58% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $78.57B | 8.51% | 9.70% | 12.91% | 18.22% |
| Becton, Dickinson and Company (BDX)vs › | $60.00B | 4.73% | 4.38% | 4.32% | 3.88% |
| Elevance Health Inc. (ELV)vs › | $81.51B | 6.65% | 6.70% | 7.11% | 7.33% |
| Cardinal Health, Inc. (CAH)vs › | $53.87B | 11.37% | 10.09% | 4.86% | -0.22% |
| HCA Healthcare, Inc. (HCA)vs › | $87.16B | 18.53% | 17.61% | 17.07% | 16.89% |
| Edwards Lifesciences Corporation (EW)vs › | $49.56B | 11.40% | 11.07% | 14.43% | 15.83% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.10B | 40.27% | 37.07% | 34.89% | 35.94% |
ROIC
8.8%
ROE
14.2%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 8.78% |
| 2024-12-31 | 6.13% |
| 2023-12-31 | 5.69% |
| 2022-12-31 | 3.89% |
| 2021-12-31 | 6.58% |
| 2020-12-31 | 2.22% |
| 2019-12-31 | 6.31% |
| 2018-12-31 | 9.65% |
| 2017-12-31 | 1.13% |
| 2016-12-31 | 8.48% |
| 2015-12-31 | 1.85% |
| 2014-12-31 | 3.69% |
| 2013-12-31 | 3.17% |
| 2012-12-31 | 6.40% |
| 2011-12-31 | 3.96% |
| 2010-12-31 | 5.36% |
| 2009-12-31 | 4.61% |
| 2008-12-31 | 5.42% |
| 2007-12-31 | 3.64% |
| 2006-12-31 | 4.34% |
| 2005-12-31 | 20.76% |
| 2004-12-31 | 18.53% |
| 2003-12-31 | 10.53% |
| 2002-12-31 | 11.46% |
| 2001-12-31 | -3.64% |
| 2000-12-31 | 16.66% |
| 1999-12-31 | 15.35% |
| 1998-12-31 | -6.47% |
| 1997-12-31 | 16.00% |
| 1996-12-31 | 14.92% |
